Details of the Drug
General Information of Drug (ID: DMPLEC0)
Drug Name |
1-(4-bromophenyl)-2-pyrrolidin-1-yl-pentan-1-one
|
|||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
CHEMBL202420; 1-(4-bromophenyl)-2-pyrrolidin-1-yl-pentan-1-one; 4-Bromo-alpha-pvp; SCHEMBL4937387; BDBM50182578; 4'-Bromo-alpha-pyrrolidinopentiophenone; 2-(Pyrrolidin-1-yl)-1-(4-bromophenyl)pentan-1-one; 1-Pentanone, 1-(4-bromophenyl)-2-(1-pyrrolidinyl)-; 1-(4-bromophenyl)-2-(pyrrolidin-1-yl)pentan-1-one
|
|||||||||||||||||||
Indication |
|
|||||||||||||||||||
Drug Type |
Small molecular drug
|
|||||||||||||||||||
Structure | ||||||||||||||||||||
3D MOL | 2D MOL | |||||||||||||||||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 310.23 | ||||||||||||||||||
Topological Polar Surface Area (xlogp) | 4.1 | |||||||||||||||||||
Rotatable Bond Count (rotbonds) | 5 | |||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 0 | |||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 2 | |||||||||||||||||||
Chemical Identifiers |
|
|||||||||||||||||||
Cross-matching ID | ||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
The Studied Disease | Discovery agent | |||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICD Disease Classification | N.A. | |||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||||||||
References